PsychedelicNewsBreaks

WednesdayOct 04, 2023 2:10 pm

PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Dismissal of Motion, Wins $2.8 Million Award

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, is reporting on the status of court action filed against it. The company announced that the Ontario Superior Court of Justice dismissed the motion to set aside an arbitration award to FSD Pharma; the motion was filed by Dr. Raza Bokhari, former FSD Pharma CEO of FSD Pharma and current CEO of Medicus Pharma Ltd. In addition, the company noted an earlier decision by the Honourable J. Douglas…

Continue Reading

FridaySep 22, 2023 11:44 am

PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Featured in InvestmentPitch Media Video

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a company building a portfolio of innovative assets and biotech solutions, was featured in an InvestmentPitch media video that discusses continued development of UNBUZZD(TM), the company’s new rapid detox drink. UNBUZZD(TM) is a proprietary formulation of natural ingredients, vitamins and minerals to help relieve the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle. Kevin Harrington, an original “shark” on the TV hit show Shark Tank and the creator of the infomercial to introduce UNBUZZD(TM), joined the program to discuss his involvement with the product and the impressive team he…

Continue Reading

MondaySep 18, 2023 11:40 am

PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Interim Results from FIH Clinical Trial of Lucid-MS

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders, today announced the receipt of an interim report for the first-in-human (“FIH”) single ascending dose phase I clinical trial evaluating the company’s novel drug candidate. The interim blinded report for Lucid-21-302 (“Lucid-MS”), an orally administered treatment for multiple sclerosis ("MS"), was issued on Aug, 17, 2023, for the first four cohorts, with an addendum report describing the results of the fifth cohort due by the end of the month. “We are…

Continue Reading

ThursdaySep 14, 2023 1:49 pm

PsychedelicNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Collaborates to Unlock the Value of Brands Through Strategic Acquisitions

Lucy Scientific Discovery (NASDAQ: LSDI), a publicly traded company focused on the development, sale, delivery, and manufacturing of psychotropic products, recently announced the acquisition of BlueSky Wellness Inc., along with its portfolio of brands, which adds psychotropic products to its catalog and expands its footprint into the global wellness market. BlueSky wellness-focused ecommerce brands include Keoni, Keoni Sport, Blush Wellness and AMMA Healing, which, in each of the last two years, have generated over $20 million in revenue. BlueSky is poised with a variety of products that range from full-spectrum oils to edible goods, gummies, topicals and beauty products. The…

Continue Reading

WednesdaySep 13, 2023 12:22 pm

PsychedelicNewsBreaks — CBDWire to Expand Reach of Green Label Expo & Green Label Summit Las Vegas 2023

CBDWire, a specialized communications platform for the CBD sector and one of the 60+ brands within the InvestorBrandNetwork (“IBN”), today announced its collaboration with the Jotia Group to serve as the media sponsor and official newswire for the highly anticipated Green Label Expo Las Vegas and Green Label Summit. These distinctive, trailblazing cannabis trade shows allow exhibitors to provide live product demonstrations to attendees and are scheduled to take place at the Nuwu Dispensary in Las Vegas on Oct. 31 – Nov. 1, 2023. IBN and CBDWire will leverage a comprehensive range of solutions to amplify recognition for participating companies,…

Continue Reading

WednesdaySep 13, 2023 11:14 am

PsychedelicNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Announces Acquisition of BlueSky Wellness, Expands Footprint in Global Wellness Market

Lucy Scientific Discovery (NASDAQ: LSDI), a publicly traded company focused on the development, sale, delivery and manufacturing of psychotropic products, is acquiring BlueSky Wellness Inc. and the BlueSky portfolio of brands. According to the announcement, the acquisition adds psychotropic products to the company’s catalog, enabling LSDI to expand its footprint in the global wellness market. BlueSky Wellness brands include Keoni, Keoni Sport, Blush Wellness and AMMA Healing, which have generated more than $20 million in revenue in each of the last two years; BlueSky products range from full-spectrum oils to edible goods, gummies, topicals and beauty products. As part of…

Continue Reading

WednesdaySep 13, 2023 10:17 am

PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Coverage Initiated by Singular Research

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders. The company today announced that Singular Research has initiated analyst coverage on FSD Pharma. The company has not paid for the research report prepared by Singular Research, and all reports on FSD Pharma prepared by analysts represent the views of such analysts and are not necessarily those of FSD Pharma. A copy of the report can be obtained directly from the analyst at Singular Research by contacting BJ…

Continue Reading

TuesdaySep 12, 2023 10:11 am

PsychedelicNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) to Acquire BlueSky Wellness Inc. in All-Stock Transaction

Lucy Scientific Discovery (NASDAQ: LSDI) is the leader in the psychotropic industry, which recently celebrated the acquisition of the intellectual property of High Times, the most iconic brand in the cannabis industry. Today the company announced an agreement to acquire BlueSky Wellness Inc. and its portfolio of brands, expanding Lucy’s footprint into the growing global wellness category by adding psychotropic products to its capabilities. BlueSky Wellness is a portfolio of plant-based brands including Keoni, Keoni Sport, Blush Wellness and AMMA Healing. It has generated over $20 million in each of the last two years through its e-commerce brands that are…

Continue Reading

FridaySep 08, 2023 12:08 pm

PsychedelicNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Strengthening Position in Projected $51B Global Cannabis Market

Lucy Scientific Discovery (NASDAQ: LSDI) is featured in a recent FinancialNewsMedia (“FNM”) Editorial. The editorial provides an overview of LSDI’s position in a global cannabis market projected to hit $51 billion this year. According to the press release, the global cannabis market has seen consistent growth year after year, with increasing legalization of cannabis fueling that growth. The release notes that a recent Statista report forecast the global cannabis market to reach $51.27 billion in 2023 with revenue expected to show an annual growth rate (“CAGR”) of 14.95%. For the purposes of the report, the cannabis market was categorized into…

Continue Reading

ThursdaySep 07, 2023 11:51 am

PsychedelicNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquires High Times Intellectual Property, Featured in Financial News Media Article

Lucy Scientific Discovery (NASDAQ: LSDI) today announced the acquisition of the intellectual property (“IP”) of High Times, an iconic brand in the cannabis industry. In addition to the Hightimes.com domain, the transaction also includes the trademarks for the Cannabis Cup and 420.com brands and their respective domain names. In exchange, High Times will receive a 19.9% stake in Lucy's outstanding stock as well as performance-based payments. “Lucy expects this acquisition to drive high margin revenue quickly and sustainably across the cannabis sector around the world. This is a great opportunity to grow the market presence of the nearly 50-year-old High…

Continue Reading